Literature DB >> 15023277

Adolescent Sexually Transmitted Diseases: Recent Developments.

Diane R. Blake1.   

Abstract

Adolescents and young adults continue to have the highest rates of sexually transmitted diseases. New chlamydia and gonorrhea diagnostic tests are being used in innovative ways to increase the number of infections that are detected. Nevertheless, challenges such as gonorrhea resistance and partner notification and treatment continue to hinder efforts to reduce the prevalence of these two bacterial infections. Although recent surveillance data suggest a decreasing trend of herpes simplex virus 2 (HSV-2) incidence among adolescents and young adults, the incidence of sexually transmitted human papillomavirus (HPV) in adolescent and young adult females remains high. Progress has been made toward the development of vaccines that may become available in the future to prevent infection with and sequelae from HSV-2 and HPV.

Entities:  

Year:  2004        PMID: 15023277     DOI: 10.1007/s11908-996-0011-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  35 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies.

Authors:  Kristen J Mertz; Richard A Voigt; Kathleen Hutchins; William C Levine
Journal:  Sex Transm Dis       Date:  2002-12       Impact factor: 2.830

3.  Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females.

Authors:  G R Burstein; J M Zenilman; C A Gaydos; M Diener-West; M R Howell; W Brathwaite; T C Quinn
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

4.  Reaching homeless youths for Chlamydia trachomatis and Neisseria gonorrhoeae screening in Denver, Colorado.

Authors:  J M Van Leeuwen; C A Rietmeijer; T LeRoux; R White; J Petersen
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

5.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

6.  Improving participation in Chlamydia screening programs: perspectives of high-risk youth.

Authors:  Diane R Blake; Margaret H Kearney; J Michael Oakes; Susan K Druker; Roger Bibace
Journal:  Arch Pediatr Adolesc Med       Date:  2003-06

7.  Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.

Authors:  W E Lafferty; L Downey; C Celum; A Wald
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

8.  Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.

Authors:  Joseph M Mrus; Frank M Biro; Bin Huang; Joel Tsevat
Journal:  Arch Pediatr Adolesc Med       Date:  2003-07

9.  Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Authors:  Lawrence Corey; Anna Wald; Raj Patel; Stephen L Sacks; Stephen K Tyring; Terri Warren; John M Douglas; Jorma Paavonen; R Ashley Morrow; Karl R Beutner; Leonid S Stratchounsky; Gregory Mertz; Oliver N Keene; Helen A Watson; Dereck Tait; Mauricio Vargas-Cortes
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

10.  The clinical and economic consequences of screening young men for genital chlamydial infection.

Authors:  Rachel H S Ginocchio; David L Veenstra; Frederick A Connell; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.